Pages that link to "Q38436991"

The following pages link to Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study (Q38436991):

Displaying 26 items.

• Parenteral anticoagulation in ambulatory patients with cancer (Q22252972) (← links)
• Anticoagulation, ferrotoxicity and the future of translational lung cancer research (Q26740335) (← links)
• Anticoagulation in combination with antiangiogenesis and chemotherapy for cancer patients: evidence and hypothesis (Q26740812) (← links)
• The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials (Q26852293) (← links)
• Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. (Q34546366) (← links)
• Clinical guide SEOM on venous thromboembolism in cancer patients (Q34553530) (← links)
• Clinical models and biochemical predictors of VTE in lung cancer (Q38205701) (← links)
• Low-molecular-weight heparins and cancer: focus on antitumoral effect (Q38376242) (← links)
• Heparin: 100 years of pleiotropic effects (Q38588071) (← links)
• Drug repurposing in oncology--patient and health systems opportunities. (Q38611707) (← links)
• Low molecular weight heparin and cancer survival: clinical trials and experimental mechanisms (Q38749053) (← links)
• Old and new applications of non-anticoagulant heparin (Q38855728) (← links)
• Key points to optimizing management and research on cancer-associated thrombosis. (Q39358771) (← links)
• Antithrombin controls tumor migration, invasion and angiogenesis by inhibition of enteropeptidase (Q40714729) (← links)
• Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers (Q42126706) (← links)
• Parenteral anticoagulation in ambulatory patients with cancer. (Q47551857) (← links)
• Primary thromboprophylaxis (PTP) in ambulatory patients with lung cancer receiving chemotherapy: A systematic review and meta-analysis of randomized controlled trials (RCTs). (Q48288156) (← links)
• Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA). (Q49888849) (← links)
• [Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy]. (Q52836172) (← links)
• Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect (Q61805375) (← links)
• Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients? (Q87850468) (← links)
• Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis? (Q90480230) (← links)
• Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis (Q90671035) (← links)
• Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients (Q92571444) (← links)
• Do lung cancer patients require routine anticoagulation treatment? A meta-analysis (Q92706745) (← links)
• Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis (Q99721347) (← links)